FDA Says Pilot Began On Schedule, 'Active' for Drugs in Philadelphia
The Food and Drug Administration’s pilot test of its partner government agency (PGA) message set in the Automated Commercial Environment began as scheduled on Aug. 19, said an agency spokesman. The pilot, which is currently open to entries of “medical…
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
products” at the ports of Philadelphia, Baltimore, and Otay Mesa, has already been “active” in Philadelphia, “where a number of pharmaceutical imports have been admitted into U.S. commerce through the new system,” he said. FDA has said it plans to start its pilot with pharmaceutical products before expanding to entries of medical devices and eventually all other FDA regulated products (see 1504220072). The agency issued a notice soliciting participants for the pilot on Aug. 27 (see 1508260014).